# Galera Therapeutics, Inc.

Galera Therapeutics, Inc. is a company headquartered in Malvern, PA, United States.

## Company overview

- **Legal name:** Galera Therapeutics, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Malvern, PA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001563577

## About

Galera Therapeutics, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001563577, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2026-03-19, it reported net income of USD 149,049,000; total assets of USD 7,196,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2025 (period ended 2025-12-31)

- **Net income:** $149.0M (USD 149,049,000)
- **Total assets:** $7.2M (USD 7,196,000)
- **Cash and equivalents:** $6.4M (USD 6,375,000)
- **Operating cash flow:** -$6.0M (USD -6,049,000)

### FY2024 (period ended 2024-12-31)

- **Net income:** -$19.0M (USD -18,957,000)
- **Total assets:** $10.1M (USD 10,101,000)
- **Cash and equivalents:** $8.3M (USD 8,289,000)
- **Operating cash flow:** -$12.1M (USD -12,145,000)

### FY2023 (period ended 2023-12-31)

- **Net income:** -$59.1M (USD -59,082,000)
- **Total assets:** $26.1M (USD 26,141,000)
- **Cash and equivalents:** $18.3M (USD 18,257,000)
- **Operating cash flow:** -$44.8M (USD -44,848,000)

### FY2022 (period ended 2022-12-31)

- **Net income:** -$62.2M (USD -62,222,000)
- **Total assets:** $44.0M (USD 44,036,000)
- **Cash and equivalents:** $4.3M (USD 4,266,000)
- **Operating cash flow:** -$43.4M (USD -43,426,000)

## Recent SEC filings

- Form 8-K — filed 2026-08-04 — period 2026-08-03 — 8-K
- Form 8-K — filed 2026-07-31 — period 2026-07-31 — 8-K
- Form 8-K — filed 2026-07-13 — period 2026-07-12 — 8-K
- Form 8-K — filed 2026-07-07 — period 2026-07-07 — 8-K
- Form 8-K — filed 2026-05-19 — period 2026-05-15 — 8-K
- Form 8-K — filed 2026-05-15 — period 2026-05-11 — 8-K
- Form 10-Q — filed 2026-05-14 — period 2026-03-31 — 10-Q
- Form 8-K — filed 2026-05-11 — period 2026-05-08 — 8-K
- Form DEF 14A — filed 2026-04-20 — period 2026-05-08 — DEF 14A
- Form 8-K — filed 2026-04-14 — period 2026-04-14 — 8-K
- Form 8-K — filed 2026-04-09 — period 2026-04-07 — 8-K
- Form 8-K — filed 2026-04-03 — period 2026-04-03 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/galera-therapeutics-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology